Your browser doesn't support javascript.
loading
[Effectiveness of an immunization campaign with group A and C meningococcal polysaccharide vaccine in controlling an outbreak of group C meningococcal disease].
Gong, Jian; Li, Cui-Yun; Dong, Bai-Qing; Huang, Jing-Zhi; Quan, Yi; Lu, Wan-Zhuan; Luo, Cheng-Hui; Mao, Wei-Cheng; Liao, He-Zhuang; Fang, Jin-Song; Cui, Xuan-Lin; Xie, Gui-Lin; Wu, Xing-Hua; Lan, Rong-Wei.
Afiliación
  • Gong J; Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention, Nanning 530028, China.
Zhonghua Liu Xing Bing Xue Za Zhi ; 29(6): 552-5, 2008 Jun.
Article en Zh | MEDLINE | ID: mdl-19040035
ABSTRACT

OBJECTIVE:

To assess the safety, immunogenicity and efficacy of group A and C meningococcal polysaccharide vaccine (A/C MPV) in response to an outbreak of group C meningococcal disease.

METHODS:

A vaccination campaign with A/C MPV was prompted 6 weeks after the use of group A MPV in Laibin city, Guangxi, where an outbreak of group C meningococcal meningitis occurred in 2002. Vaccinees were observed for local and systemic reactions after the vaccination and followed up for the meningococcal disease for 5 years. Blood samples were collected from 71 people in the epidemic and 43 in the non-epidemic areas before and 1 month after the vaccination and examined by ELISA to detect IgG antibodies to group A and C polysaccharides.

RESULTS:

The vaccination coverage was 97%. No significant adverse reactions were observed. The positive rates of group C antibodies after vaccination was between 97.67% and 100% among the populations in the epidemic and non-epidemic areas, as well as among those negative and positive for group C antibodies prior to the vaccination. The geometric mean anti-C concentrations ranged 30.81 microg/ml to 37.44 microg/ml, showing no significant difference between groups. The incidence rate of meningococcal disease in students with timely immunization (218.58/100,000) dropped by 69.02%, when compared to that in those with delayed immunization (705.72/100,000). No clinical cases were identified during the follow-up period of 15,760 person-years.

CONCLUSION:

The vaccination campaign with the Chinese group A/C MPV seemed successful in controlling the group C meningococcal outbreak. The vaccine was shown to be safe even administered after the group A vaccine only 6 weeks apart. It could induce high levels of antibodies in vulnerable population and significantly increase antibody levels in seropositive individuals, thus providing a protection of at least 5 years.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 3_ND / 4_TD Problema de salud: 2_enfermedades_transmissibles / 3_zoonosis / 4_meningitis Asunto principal: Vacunación Masiva / Brotes de Enfermedades / Vacunas Meningococicas / Meningitis Meningocócica Límite: Adolescent / Child / Child, preschool / Humans / Infant País/Región como asunto: Asia Idioma: Zh Revista: Zhonghua Liu Xing Bing Xue Za Zhi Año: 2008 Tipo del documento: Article País de afiliación: China
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 3_ND / 4_TD Problema de salud: 2_enfermedades_transmissibles / 3_zoonosis / 4_meningitis Asunto principal: Vacunación Masiva / Brotes de Enfermedades / Vacunas Meningococicas / Meningitis Meningocócica Límite: Adolescent / Child / Child, preschool / Humans / Infant País/Región como asunto: Asia Idioma: Zh Revista: Zhonghua Liu Xing Bing Xue Za Zhi Año: 2008 Tipo del documento: Article País de afiliación: China
...